Biotech Stocks List USA 2024: FKnol.com

Most Read Articles: Warren Buffett's Stock Picking Indicators, and Investment Strategies for a Bear Market.
Biotechnology has emerged as one of the key areas of interest amid the Health Care sector. Hundreds of biotech companies have mushroomed whose size varies from 5 person teams to thousands of employees who are involved in path-breaking research, associated development, and attempts to find cure to a variety of diseases and ailments. Companies in the biotechnology subsector usually have a very high operating cost owing to their research-, development-, and testing-focused activities which may not only take years to complete, but the end result is also highly uncertain. Success may lead to the biotech company coming out with a high-price patented drug that can make millions or billions making the stock a multi-bagger, while a failure can lead to a complete wipeout of equity value. Investors in such biotech stocks should be prepared for a volatile change in stock prices.

As of writing, FKnol has the following Biotech stocks in its database. This article presents the performance of the Biotech stocks in a tabular form making it easy for individuals to sort the list on the desired parameters of preference. Details are based on the market data for the year 2024 till date. This article presents a list of all Biotech stocks, which can be sorted and assessed for the past performance of the Biotech stocks based on market capitalization values, stock price, price changes, percentage price changes and 52-week high-low price ranges. Percentage change is calculated based on the price changes observed from the end of the previous year to the date of Dec 2, 2024.

Sector-wise U.S. Stock Screener

There are a total of 645 company stocks in FKnol records which have business operations in the Biotech segment / category. Explore the full list as follows.
This page is updated every week/month. Bookmark this site to track the best performing stocks regularly.

Top Performing Biotech StocksAll Biotech StocksAll Biotech ETFsTop Dividend-paying Biotech StocksTop Biotech Stocks for Dec 2024

Performance of Biotech Stocks

🡄 1-24 25-48 49-72 73-96 97-120 121-144 145-168 169-192 193-216 217-240 241-264 265-288 289-312 313-336 337-360 361-384 385-408 409-432 433-456 457-480 481-504 505-528 529-552 553-576 577-600 601-624 625-645 🡆

Company (Ticker)	Market Cap	%YTD Gains	Company Description	Stock Price	52-wk Price Range	PE fwd	PE trail	EPS ttm
Sorted by Company Name. Click on the arrow buttons to sort the table as per the desired column
1) 180 Life Sciences Corp. (ATNF)	$4.62 million	-41.33%	180 Life Sciences Corp., a clinical-stage biotechnology company, engages in the development of novel drugs for unmet medical needs in chronic pain, ...See Detailed Company Profile	$2.38	$1.16 - $17.75	10.86	0	-4.49
2) 22nd Century (XXII)	$4.80 million	-96.5%	22nd Century Group, Inc., a plant biotechnology company, provides technology that allows increasing or decreasing the level of nicotine and other nicotinic alkaloids in tobacco plants, and cannabinoid ...See Detailed Company Profile Dividend History List of ETFs holding XXII	$0.1000	$0.08 - $4.31	-4.24	0	-14.13
3) Stock Biotech ZVZZT Biotech Corp Ltd. (ZVZZT)	Members Only! Login / Register to view		The Biotech stock belonging to the Biotech category, Healthcare sector and Biotechnology sub-sector of the US market has the following business profile. ...See Detailed Company Profile	Members Only! Login / Register to view or

4) 60 Degrees Pharmaceuticals (SXTP)	$2.53 million	-91.24%	60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and ...See Detailed Company Profile Dividend History	$1.07	$0.70 - $18.36	-1.2	0	-9.19
5) 89Bio (ETNB)	$1.13 billion	-15.49%	89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate, BIO89-100, a glycoPEGylated analog of fibroblast growth factor 21 that is being developed for the treatment of nonalcoholic steatohepatitis. The company also intends to develop BIO89-100 for the treat ...See Detailed Company Profile Dividend History List of ETFs holding ETNB	$9.44	$7.00 - $16.63	23.38	0	-2.91
6) Stock Biotech ZVZZT Biotech Corp Ltd. (ZVZZT)	Members Only! Login / Register to view		The Biotech stock belonging to the Biotech category, Healthcare sector and Biotechnology sub-sector of the US market has the following business profile. ...See Detailed Company Profile	Members Only! Login / Register to view or

7) AbCellera Biologics Inc. (ABCL)	$841.44 million	-46.93%	AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, AI-powered drug discovery platform searches and analyzes the database of ...See Detailed Company Profile	$3.03	$2.34 - $6.05	25.23	0	-0.6
8) Abeona Therapeutics (ABEO)	$276.47 million	26.54%	Abeona Therapeutics, Inc. (Abeona), formerly PlasmaTech Biopharmaceuticals, Inc., incorporated on June 22, 1989, is focused on developing and delivering gene therapy and plasma-based products for rare diseases. The Companys lead ...See Detailed Company Profile Dividend History List of ETFs holding ABEO	$6.34	$3.05 - $9.01	-1.27	0	-2.29
9) Stock Biotech ZVZZT Biotech Corp Ltd. (ZVZZT)	Members Only! Login / Register to view		The Biotech stock belonging to the Biotech category, Healthcare sector and Biotechnology sub-sector of the US market has the following business profile. ...See Detailed Company Profile Dividend History	Members Only! Login / Register to view or

10) Absci Corporation (ABSI)	$326.21 million	-25%	Absci Corporation, an AI-powered synthetic biology company, offers biologic drug candidates and production cell lines using integrated drug creation ...See Detailed Company Profile	$3.15	$1.74 - $6.72	0	0	-0.94
11) ABVC Biopharma, Inc. (ABVC)	$6.54 million	-55.16%	American BriVision (Holding) Corporation, a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in ...See Detailed Company Profile	$0.5200	$0.41 - $2.45	17.4	0	-0.97
12) Stock Biotech ZVZZT Biotech Corp Ltd. (ZVZZT)	Members Only! Login / Register to view		The Biotech stock belonging to the Biotech category, Healthcare sector and Major Pharmaceuticals sub-sector of the US market has the following business profile. ...See Detailed Company Profile Dividend History List of ETFs holding Stock	Members Only! Login / Register to view or

13) ACADIA Pharma (ACAD)	$2.75 billion	-46.95%	ACADIA Pharmaceuticals Inc., incorporated on January 16, 1997, is a biopharmaceutical company. The Company is focused on the development and commercialization of medicines for central nervous system (CNS) disorders. The ...See Detailed Company Profile Dividend History List of ETFs holding ACAD	$16.61	$14.15 - $32.59	0	21.42	0.78
14) Acelyrin (SLRN)	$457.33 million	-40.08%	Acelyrin, Inc., a clinical biopharma company, focuses on identifying, acquiring, and accelerating the development and commercialization of transformative ...See Detailed Company Profile Dividend History	$4.47	$3.36 - $8.89	12.87	0	-2.68
15) Stock Biotech ZVZZT Biotech Corp Ltd. (ZVZZT)	Members Only! Login / Register to view		The Biotech stock belonging to the Biotech category, Healthcare sector and Healthcare sub-sector of the US market has the following business profile. ...See Detailed Company Profile Dividend History List of ETFs holding Stock	Members Only! Login / Register to view or

16) Achilles Therapeutics plc (ACHL)	$43.57 million	20.94%	Achilles Therapeutics Plc, a clinical stage immuno-oncology biopharmaceutical company, develops precision T cell therapies to treat various types of solid ...See Detailed Company Profile	$1.07	$0.63 - $1.76	8.18	0	-1.66
17) Aclaris Therapeutics (ACRS)	$252.29 million	277.14%	Aclaris Therapeutics, Inc., incorporated on July 13, 2012, is a clinical-stage specialty pharmaceutical company. The Company is focused on identifying, developing and commercializing differentiated drugs for the treatment of dermatological ...See Detailed Company Profile Dividend History List of ETFs holding ACRS	$3.96	$0.80 - $5.17	102.45	0	-0.52
18) Stock Biotech ZVZZT Biotech Corp Ltd. (ZVZZT)	Members Only! Login / Register to view		The Biotech stock belonging to the Biotech category, Healthcare sector and Biotechnology sub-sector of the US market has the following business profile. ...See Detailed Company Profile	Members Only! Login / Register to view or

19) Actinium Pharma (ATNM)	$43.99 million	-72.24%	Actinium Pharmaceuticals, Inc. (Actinium), incorporated on March 20, 2013, is a clinical-stage biopharmaceutical company engaged in developing cancer treatments. The Company is engaged in developing therapies for diseases using its ...See Detailed Company Profile Dividend History List of ETFs holding ATNM	$1.41	$1.33 - $10.24	-69.83	0	-1.4
20) Acumen Pharmaceuticals, Inc. (ABOS)	$136.83 million	-38.8%	Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapeutics for the treatment of Alzheimers and ...See Detailed Company Profile	$2.35	$2.08 - $5.09	17.72	0	-1.37
21) Stock Biotech ZVZZT Biotech Corp Ltd. (ZVZZT)	Members Only! Login / Register to view		The Biotech stock belonging to the Biotech category, Healthcare sector and Biotechnology sub-sector of the US market has the following business profile. ...See Detailed Company Profile	Members Only! Login / Register to view or

22) Adagene Inc. (ADAG)	$95.71 million	13.4%	Adagene Inc., a clinical stage biopharmaceutical company, engages in the research, development, and production of monoclonal antibody drugs for cancers. ...See Detailed Company Profile	$2.19	$1.36 - $4.38	0	0	-0.72
23) Adaptimmune Therapeutics (ADAP)	$174.77 million	-9.21%	Adaptimmune Therapeutics plc, incorporated on December 03, 2014, is a clinical-stage biopharmaceutical company. The Company is focused on cancer immunotherapy products based on its Specific Peptide Enhanced Affinity Receptor (SPEAR) ...See Detailed Company Profile Dividend History List of ETFs holding ADAP	$0.7200	$0.43 - $2.05	7.49	0	-0.21
24) Stock Biotech ZVZZT Biotech Corp Ltd. (ZVZZT)	Members Only! Login / Register to view		The Biotech stock belonging to the Biotech category, Healthcare sector and Biotechnology sub-sector of the US market has the following business profile. ...See Detailed Company Profile Dividend History List of ETFs holding Stock	Members Only! Login / Register to view or